Challenges in Providing Treatment and Care for Viral Hepatitis among Individuals Co-Infected with HIV in Resource-Limited Settings

AIDS Research and Treatment

Volumn 2012, Issue , 2012, Pages

  Maek A Nantawat, Wirach ^a   Avihingsanon, Anchalee ^a   Ohata, Pirapon June ^a  

^a THAI RED CROSS AIDS RESEARCH CENTRE   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84873854655     PISSN: 20901240     EISSN: 20901259     Source Type: Journal    
DOI: 10.1155/2012/948059     Document Type: Review

References (79)

1. Vong S., Perz J. F., Sok S., Som S., Goldstein S., Hutin Y., Tulloch J., Rapid assessment of injection practices in Cambodia, 2002. BMC Public Health 2005 5, article 56 2-s2.0-23044433690 10.1186/1471-2458-5-56 (Pubitemid 41074282)
2. Tran H. T. T., Ushijima H., Quang V. X., Phuong N., Li T. C., Hayashi S., Lien T. X., Sata T., Abe K., Prevalence of hepatitis virus types B through E and genotypic distribution of HBV and HCV in Ho Chi Minh City, Vietnam. Hepatology Research 2003 26 4 275 280 2-s2.0-0141838652 10.1016/S1386-6346(03) 00166-9 (Pubitemid 37184515)
3. Jutavijittum P., Yousukh A., Samountry B., Samountry K., Ounavong A., Thammavong T., Keokhamphue J., Toriyama K., Seroprevalence of hepatitis B and C virus infections among Lao blood donors. Southeast Asian Journal of Tropical Medicine and Public Health 2007 38 4 674 679 2-s2.0-34548274633
4. Wiwanitkit V., An overview of a hepatitis B serology screening check-up program among Thai workers. Viral Immunology 2002 15 4 647 649 2-s2.0-0036456009 (Pubitemid 35448777)
5. Nelwan E. J., Van Crevel R., Alisjahbana B., Indrati A. K., Dwiyana R. F., Nuralam N., Pohan H. T., Jaya I., Meheus A., Van Der Ven A., Human immunodeficiency virus, hepatitis B and hepatitis C in an Indonesian prison: prevalence, risk factors and implications of HIV screening. Tropical Medicine and International Health 2010 15 12 1491 1498 2-s2.0-78649693880 10.1111/j.1365-3156.2010.02655.x
6. Yanase Y., Ohida T., Kaneita Y., Agdamag D. M. D., Leaño P. S. A., Gill C. J., The prevalence of HIV, HBV and HCV among Filipino blood donors and overseas work visa applicants. Bulletin of the World Health Organization 2007 85 2 131 137 2-s2.0-33846820204 10.2471/BLT.06.033365 (Pubitemid 46203943)
7. Sebastian V. J., Bhattacharya S., Ray S., Daud J. H., Prevalence of hepatitis-B surface antigen in the pregnant women of Brunei Darussalam. The Southeast Asian Journal of Tropical Medicine and Public Health 1990 21 1 123 127 2-s2.0-0025394874
8. Alexander M. J., Sinnatamby A. S., Rohaimah M. J., Harun A. H., Ng J. S., Incidence of hepatitis B infection in Brunei Darussalam-analysis of racial distribution. Annals of the Academy of Medicine Singapore 1990 19 3 344 346 2-s2.0-0025427313
9. Luksamijarulkul P., Kaepan W., Klamphakorn S., Hepatitis B virus sero-markers, hepatitis C virus antibody and risk behaviors among middle age and older Thai males. Southeast Asian Journal of Tropical Medicine and Public Health 2007 38 1 45 52 2-s2.0-33947583834
10. Sungkanuparph S., Vibhagool A., Manosuthi W., Kiertiburanakul S., Atamasirikul K., Aumkhyan A., Thakkinstian A., Prevalence of hepatitis B virus and hepatitis C virus co-infection with human immunodeficiency virus in Thai patients: a tertiary-care-based study. Journal of the Medical Association of Thailand 2004 87 11 1349 1354 2-s2.0-13744252975 (Pubitemid 40238559)
11. Law W. P., Dore G. J., Duncombe C. J., Mahanontharit A., Boyd M. A., Ruxrungtham K., Lange J. M. A., Phanuphak P., Cooper D. A., Risk of severe hepatotoxicity associated with antiretroviral therapy in the HIV-NAT Cohort, Thailand, 1996-2001. AIDS 2003 17 15 2191 2199 2-s2.0-0242364714 10.1097/00002030-200310170-00007 (Pubitemid 37338892)
12. Kiertiburanakul S., rasal@mahidol.ac.th Chotiprasitsakul D., Atamasirikul K., Sungkanuparph S., Late and low compliance with hepatitis B serology screening among HIV-infected patients in a resource-limited setting: an issue to improve HIV care. Current HIV Research 2011 9 1 54 60 10.2174/ 157016211794582669
13. Sungkanuparph S., Wongprasit P., Manosuthi W., Atamasirikul K., Compliance with hepatitis B and hepatitis C virus infection screening among HIV-1 infected patients in a resource-limited setting. The Southeast Asian Journal of Tropical Medicine and Public Health 2008 39 5 863 866 2-s2.0-60249084223
14. Leeratanapetch N. S. W., Hepatitis B virus and hepatitis C virus co-infection with HIV patients at Khon Kaen Hospital. Khon Kaen Hospital Medical Journal 2008 32 2 229 238
15. Theamboonlers A., Tangkijvanich P., Pramoolsinsap C., Poovorawan Y., Genotypes and subtypes of hepatitis B virus in Thailand. Southeast Asian Journal of Tropical Medicine and Public Health 1998 29 4 786 791 (Pubitemid 128709192)
16. Theamboonlers A., Jantaradsamee P., Kaew-In N., Tangkijvanich P., Hirsch P., Poovorawan Y., The predominant genotypes of hepatitis B virus in Thailand. Annals of Tropical Medicine and Parasitology 1999 93 7 737 743 2-s2.0-0032753682 10.1080/00034989957998 (Pubitemid 29527696)
17. Tangkijvanich P., Mahachai V., Komolmit P., Fongsarun J., Theamboonlers A., Poovorawan Y., Hepatitis B virus genotypes and hepatocellular carcinoma in Thailand. World Journal of Gastroenterology 2005 11 15 2238 2243 2-s2.0-18744409337 (Pubitemid 40691330)
18. Utama A., Purwantomo S., Siburian M. D., Dhenni R., Gani R. A., Hasan I., Sanityoso A., Miskad U. A., Akil F., Yusuf I., Achwan W. A., Soemohardjo S., Lelosutan S. A. R., Martamala R., Lukito B., Budihusodo U., Lesmana L. A., Sulaiman A., Tai S., Hepatitis B virus subgenotypes and basal core promoter mutations in Indonesia. World Journal of Gastroenterology 2009 15 32 4028 4036 2-s2.0-69449103212 10.3748/wjg.15.4028
19. Utama A., Octavia T. I., Dhenni R., Miskad U. A., Yusuf I., Tai S., Hepatitis B virus genotypes/subgenotypes in voluntary blood donors in Makassar, South Sulawesi, Indonesia. Virology Journal 2009 6, article 128 2-s2.0-69449096237 10.1186/1743-422X-6-128
20. Sa-nguanmoo P., Tangkijvanich P., Thawornsuk N., Vichaiwattana P., Prianantathavorn K., Theamboonlers A., Tanaka Y., Poovorawan Y., Molecular epidemiological study of hepatitis B virus among migrant workers from Cambodia, Laos, and Myanmar to Thailand. Journal of Medical Virology 2010 82 8 1341 1349 2-s2.0-77956574501 10.1002/jmv.21828
21. Suwannakarn K., Tangkijvanich P., Thawornsuk N., Theamboonlers A., Tharmaphornpilas P., Yoocharoen P., Chongsrisawat V., Poovorawan Y., Molecular epidemiological study of hepatitis B virus in Thailand based on the analysis of pre-S and S genes. Hepatology Research 2008 38 3 244 251 2-s2.0-38849200279 10.1111/j.1872-034X.2007.00254.x (Pubitemid 351193952)
22. Jilg W., Delhoune C., Deinhardt F., Hepatitis B surface antigen (HBsAg) subtype-specific antibodies in persons vaccinated against hepatitis B. Journal of Medical Virology 1984 13 2 171 178 (Pubitemid 14152574)
23. Quan V. M., Go V. F., Nam L. V., Bergenstrom A., Thuoc N. P., Zenilman J., Latkin C., Celentano D. D., Risks for HIV, HBV, and HCV infections among male injection drug users in northern Vietnam: a case-control study. AIDS Care 2009 21 1 7 16 2-s2.0-57649138569 10.1080/09540120802017610
24. Jatapai A., Nelson K. E., Chuenchitra T., Kana K., Eiumtrakul S., Sunantarod E., Rangsin R., Prevalence and risk factors for hepatitis C virus infection among young Thai men. American Journal of Tropical Medicine and Hygiene 2010 83 2 433 439 2-s2.0-77955643130 10.4269/ajtmh.2010.09-0749
25. Tanimoto T., Cuong N. H., Ishizaki A., Chung P. T. T., Huyen H. T. T., Trung N. V., Kageyama S., Oka S., Van Thuc P., Ichimura H., Multiple routes of hepatitis C virus transmission among injection drug users in Hai Phong, Northern Vietnam. Journal of Medical Virology 2010 82 8 1355 1363 2-s2.0-77956587634 10.1002/jmv.21787
26. Kageyama S., Agdamag D. M. D., Alesna E. T., Abellanosa-Tac-An I. P., Corpuz A. C., Telan E. F. O., Que E. R., Leaño P. S. A., Jereza L. D., Emphasis Y. E. E., Prasetyo A. A., Tanimoto T., Ichimura H., Tracking the entry routes of hepatitis C virus as a surrogate of HIV in an HIV-low prevalence country, the Philippines. Journal of Medical Virology 2009 81 7 1157 1162 2-s2.0-67649989071 10.1002/jmv.21516
27. Jamieson D. J., Skunodom N., Chaowanachan T., Roongpisuthipong A., Bower W. A., Chotpitayasunondh T., Bhanich Supapol W., Kuhnert W. L., Siriwasin W., Wiener J., Chearskul S., McConnell M. S., Shaffer N., Infection with hepatitis C virus among HIV-infected pregnant women in Thailand. Infectious Diseases in Obstetrics and Gynecology 2008 2008 7 2-s2.0-59549101379 10.1155/2008/840948 840948
28. Akkarathamrongsin S., Praianantathavorn K., Hacharoen N., Theamboonlers A., Tangkijvanich P., Tanaka Y., Mizokami M., Poovorawan Y., Geographic distribution of hepatitis C virus genotype 6 subtypes in Thailand. Journal of Medical Virology 2010 82 2 257 262 2-s2.0-74549117134 10.1002/jmv.21680
29. Utama A., autama@mrinstitute.org Tania N. P., Dhenni R., Gani R. A., Hasan I., Sanityoso A., Lelosutan S. A.R., Martamala R., Lesmana L. A., Sulaiman A., Tai S., Genotype diversity of hepatitis C virus (HCV) in HCV-associated liver disease patients in Indonesia. Liver International 2010 30 8 1152 1160 10.1111/j.1478-3231.2010.02280.x
30. Akkarathamrongsin S., Praianantathavorn K., Hacharoen N., Theamboonlers A., Tangkijvanich P., Poovorawan Y., Seroprevalence and genotype of Hepatitis C virus among immigrant workers from Cambodia and Myanmar in Thailand. Intervirology 2010 54 1 10 16 2-s2.0-77955120257 10.1159/000318884
31. Colin J. F., Cazals-Hatem D., Loriot M. A., Martinot-Peignoux M., Pham B. N., Auperin A., Degott C., Benhamou J. P., Erlinger S., Valla D., Marcellin P., Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men. Hepatology 1999 29 4 1306 1310 2-s2.0-0032953751 (Pubitemid 29168769)
32. Di Martino V., Thevenot T., Colin J. F., Boyer N., Martinot M., Degos F., Coulaud J. P., Vilde J. L., Vachon F., Degott C., Valla D., Marcellin P., Influence of HIV infection on the response to interferon therapy and the long-term outcome of chronic hepatitis B. Gastroenterology 2002 123 6 1812 1822 2-s2.0-0036892339 10.1053/gast.2002.37061 (Pubitemid 35408305)
33. Thio C. L., Seaberg E. C., Skolasky R. Jr., Phair J., Visscher B., Muñoz A., Thomas D. L., HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet 2002 360 9349 1921 1926 2-s2.0-0037079352 10.1016/S0140-6736(02)11913-1 (Pubitemid 35472132)
34. Clifford G. M., Rickenbach M., Polesel J., Dal Maso L., Steffen I., Ledergerber B., Rauch A., Probst-Hensch N. M., Bouchardy C., Levi F., Franceschi S., Battegay M., Bernasconi E., Böni J., Bucher H. C., Bürgisser P., Calmy A., Cattacin S., Cavassini M., Dubs R., Egger M., Elzi L., Fischer M., Flepp M., Fontana A., Francioli P., Furrer H., Fux C., Gorgievski M., Günthard H., Hirsch H., Hirschel B., Hösli I., Kahlert C., Kaiser L., Karrer U., Kind C., Klimkait T., Ledergerber B., Martinetti G., Martinez B., Müller N., Nadal D., Opravil M., Paccaud F., Pantaleo G., Rauch A., Regenass S., Rickenbach M., Rudin C., Schmid P., Schultze D., Schüpbach J., Speck R., Taffé P., Telenti A., Trkola A., Vernazza P., Weber R., Yerly S., Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma. AIDS 2008 22 16 2135 2141 2-s2.0-55249118634 10.1097/QAD. 0b013e32831103ad
35. Chotiprasitsakul D. W. P., Atamasirikul K., Sungkanuparph S., Screening of hepatitis B virus infection among HIV infected patients receiving antiretroviral therapy. Journal of Infectious Diseases and Antimicrobial Agents 2010 27 2 69 75
36. Zhou J., Dore G. J., Zhang F., Lim P. L., Chen Y. M. A., Hepatitis B and C virus coinfection in the TREAT Asia HIV Observational Database. Journal of Gastroenterology and Hepatology 2007 22 9 1510 1518 2-s2.0-34547983689 10.1111/j.1440-1746.2007.05062.x (Pubitemid 47274591)
37. Jongjirawisan Y., Ungulkraiwit P., Sungkanuparph S., Isolated antibody to hepatitis B core antigen in HIV-1 infected patients and a pilot study of vaccination to determine the anamnestic response. Journal of the Medical Association of Thailand 2006 89 12 2028 2034 2-s2.0-33845624705 (Pubitemid 44956681)
38. Hung C. C., Hsiao C. F., Gandhi R. T., McGovern B., Lee H., Sax P., Isolated Antibody to Hepatitis B Core Antigen in Individuals Infected with HIV-1. Clinical Infectious Diseases 2003 37 9 1275 1277 2-s2.0-0242574926 10.1086/378896 (Pubitemid 37372523)
39. Neau D., Winnock M., Jouvencel A. C., Faure M., Castéra L., Legrand E., Lacoste D., Ragnaud J. M., Dupon M., Fleury H., Lafon M. E., Dabis F., Occult hepatitis B virus infection in HIV-infected patients with isolated antibodies to hepatitis B core antigen: aquitaine cohort, 2002-2003. Clinical Infectious Diseases 2005 40 5 750 753 2-s2.0-20144373431 10.1086/427882 (Pubitemid 40381353)
40. Gandhi R. T., rgandhi@partners.org Wurcel A., Lee H., McGovern B., Boczanowski M., Gerwin R., Corcoran C. P., Szczepiorkowski Z., Toner S., Cohen D. E., Sax P. E., Ukomadu C., Isolated antibody to hepatitis B core antigen in human immunodeficiency virus type-1-infected individuals. Clinical Infectious Diseases 2003 36 12 1602 1605 10.1086/375084 (Pubitemid 36783346)
41. French A. L., Lin M. Y., Evans C. T., Benning L., Glesby M. J., Young M. A., Operskalski E. A., Augenbraun M., Peters M., Long-term serologic follow-up of isolated hepatitis b core antibody in hiv-infected and hiv-uninfected women. Clinical Infectious Diseases 2009 49 1 148 154 2-s2.0-66949165800 10.1086/599610
42. Eduarde Silva A., McMahon B. J., Parkinson A. J., Sjogren M. H., Hoofnagle J. H., Di Bisceglie A. M., Hepatitis B virus DNA in persons with isolated antibody to hepatitis B core antigen who subsequently received hepatitis B vaccine. Clinical Infectious Diseases 1998 26 4 895 897 2-s2.0-17344367723 (Pubitemid 28180325)
43. Hofer M., Joller-Jemelka H. I., Grob P. J., Lüthy R., Opravil M., Frequent chronic hepatitis B virus infection in HIV-infected patients positive for antibody to hepatitis B core antigen only. European Journal of Clinical Microbiology and Infectious Diseases 1998 17 1 6 13 10.1007/BF01584356 (Pubitemid 28072282)
44. Chung H. T., Lee J. S. K., Lok A. S. F., Prevention of posttransfusion hepatitis B and C by screening for antibody to hepatitis C virus and antibody to HBcAg. Hepatology 1993 18 5 1045 1049 2-s2.0-0027442440 10.1016/0270-9139(93) 90455-V (Pubitemid 23320430)
45. Dickson R. C., Everhart J. E., Lake J. R., Wei Y., Seaberg E. C., Wiesner R. H., Zetterman R. K., Pruett T. L., Ishitani M. B., Hoofnagle J. H., Detre K. M., Demetris A. J., Belle S., Wei Y., Lombardero M., Seaberg E., Lawlor S., Eng H., Fitzgerald S., Haber J., Swanson G. L., Wiesner R., Krom R., Porayko M. K., Schwerman L., Groettum C., Zetterman R. K., Shaw B. Jr., Taylor K., Ascher N., Lake J., Bremer-Kamp C., Everhart J., Shores S., Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. Gastroenterology 1997 113 5 1668 1674 10.1053/gast.1997.v113.pm9352871 (Pubitemid 27461255)
46. Hoofnagle J. H., Seeff L. B., Bales Z. B., Zimmerman H. J., Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen. New England Journal of Medicine 1978 298 25 1379 1383 2-s2.0-0018103533 (Pubitemid 8358627)
47. Núñez M., Ríos P., Pérez-Olmeda M., Soriano V., Lack of "occult" hepatitis B virus infection in HIV-infected patients. AIDS 2002 16 15 2099 2101 2-s2.0-0037131197 10.1097/00002030- 200210180-00024 (Pubitemid 35205282)
48. Douglas D. D., Taswell H. F., Rakela J., Rabe D., Absence of hepatitis B virus DNA detected by polymerase chain reaction in blood donors who are hepatitis B surface antigen negative and antibody to hepatitis B core antigen positive from a United States population with a low prevalence of hepatitis B serologic markers. Transfusion 1993 33 3 212 216 2-s2.0-0027476078 (Pubitemid 23073643)
49. Thomson E. C., Nastouli E., Main J., Karayiannis P., Eliahoo J., Muir D., McClure M. O., Delayed anti-HCV antibody response in HIV-positive men acutely infected with HCV. AIDS 2009 23 1 89 93 2-s2.0-58149129415 10.1097/QAD. 0b013e32831940a3
50. Scott C., Day S., Low E., Sullivan A., Atkins M., Asboe D., Unselected hepatitis C screening of men who have sex with men attending sexual health clinics. Journal of Infection 2010 60 5 351 353 2-s2.0-77952542696 10.1016/j.jinf.2010.01.013
51. Gilleece Y. C., Browne R. E., Asboe D., Atkins M., Mandalia S., Bower M., Gazzard B. G., Nelson M. R., Transmission of hepatitis C virus among HIV-positive homosexual men and response to a 24-week course of pegylated interferon and ribavirin. Journal of Acquired Immune Deficiency Syndromes 2005 40 1 41 46 2-s2.0-24144434928 10.1097/01.qai.0000174930.64145.a9 (Pubitemid 41233203)
52. Wiwanitkit V., Alpha fetoprotein for screening for hepatocellular cancer in populations with viral hepatitis B: an appraisal of Thai reports. Asian Pacific Journal of Cancer Prevention 2005 6 4 535 536 2-s2.0-33646674691
53. Tangkijvanich P., Anukulkarnkusol N., Suwangool P., Lertmaharit S., Hanvivatvong O., Kullavanijaya P., Poovorawan Y., Clinical characteristics and prognosis of hepatocellular carcinoma: analysis based on serum alpha-fetoprotein levels. Journal of Clinical Gastroenterology 2000 31 4 302 308 2-s2.0-0033651369 10.1097/00004836-200012000-00007
54. Komindr A., Praditphol N., Suphanpayak S., Sae-Eaw R., Nussati A., Tujinda S., Kongteeraphap P., Intaraksa S., Rukchampong R., Deesawat T., Correlation of HBV and HCV with CH, LC, HCC in liver biopsied tissue at Rajavithi Hospital. Journal of the Medical Association of Thailand 2005 88 6 788 809 2-s2.0-22744434644 (Pubitemid 41032777)
55. Avihingsanon A., Lewin S. R., Kerr S., Chang J. J., Piyawat K., Napissanant N., Matthews G. V., Dore G. J., Bowden S., Lange J., Ruxrungtham K., Efficacy of tenofovir disoproxil fumarate/emtricitabine compared with emtricitabine alone in antiretroviral-naive HIV-HBV coinfection in Thailand. Antiviral Therapy 2010 15 6 917 922 2-s2.0-77957358835 10.3851/IMP1645
56. Matthews G. V., Avihingsanon A., Lewin S. R., Amin J., Rerknimitr R., Petcharapirat P., Marks P., Sasadeusz J., Cooper D. A., Bowden S., Locarnini S., Ruxrungtham K., Dore G. J., A randomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naïve individuals in Thailand. Hepatology 2008 48 4 1062 1069 2-s2.0-54449097612 10.1002/hep.22462
57. Slavenburg S., Weggelaar I., Van Oijen M. G. H., Drenth J. P. H., Optimal length of antiviral therapy in patients with hepatitis C virus genotypes 2 and 3: a meta-analysis. Antiviral Therapy 2009 14 8 1139 1148 2-s2.0-73449094187 10.3851/IMP1464
58. Singal A. K., Anand B. S., Tailoring treatment duration to 12 to 16 weeks in hepatitis C genotype 2 or 3 with rapid virologic response: systematic review and meta-analysis of randomized controlled trials. Journal of Clinical Gastroenterology 2010 44 8 583 587 2-s2.0-77955985490 10.1097/MCG. 0b013e3181d7a46c
59. Martin-Carbonero L., Nuñez M., Mariño A., Alcocer F., Bonet L., García-Samaniego J., López-Serrano P., Cordero M., Portu J., Soriano V., vsoriano@dragonet.es Undetectable hepatitis C virus RNA at week 4 as predictor of sustained virological response in HIV patients with chronic hepatitis C. AIDS 2008 22 1 15 21 10.1097/QAD.0b013e3282f1da99 (Pubitemid 350294873)
60. Berg T., Carosi G., Optimizing outcomes in patients with hepatitis C virus genotype 2 or 3. Antiviral Therapy 2008 13 1 17 22 2-s2.0-42149111628 (Pubitemid 351542494)
61. Mangia A., Thompson A. J., Santoro R., Piazzolla V., Tillmann H. L., Patel K., Shianna K. V., Mottola L., Petruzzellis D., Bacca D., Carretta V., Minerva N., Goldstein D. B., McHutchison J. G., An IL28B polymorphism determines treatment response of hepatitis C virus genotype 2 or 3 patients who do not achieve a rapid virologic response. Gastroenterology 2010 139 3 821 827 2-s2.0-77956134252 10.1053/j.gastro.2010.05.079
62. Thomas D. L., Thio C. L., Martin M. P., Qi Y., Ge D., Ohuigin C., Kidd J., Kidd K., Khakoo S. I., Alexander G., Goedert J. J., Kirk G. D., Donfield S. M., Rosen H. R., Tobler L. H., Busch M. P., McHutchison J. G., Goldstein D. B., Carrington M., Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 2009 461 7265 798 801 2-s2.0-70349966196 10.1038/nature08463
63. Ge D., Fellay J., Thompson A. J., Simon J. S., Shianna K. V., Urban T. J., Heinzen E. L., Qiu P., Bertelsen A. H., Muir A. J., Sulkowski M., McHutchison J. G., Goldstein D. B., Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 2009 461 7262 399 401 2-s2.0-70349292099 10.1038/nature08309
64. Scherzer T.-M., Hofer H., Staettermayer A. F., Rutter K., Beinhardt S., Steindl-Munda P., Kerschner H., Kessler H. H., Ferenci P., peter. ferenci@meduniwien.ac.at Early virologic response and IL28B polymorphisms in patients with chronic hepatitis C genotype 3 treated with peginterferon alfa-2a and ribavirin. Journal of Hepatology 2011 54 5 866 871 10.1016/j.jhep.2010.08. 024
65. Moghaddam A., Melum E., Reinton N., Ring-Larsen H., Verbaan H., Bjøro K., Dalgard O., odalgard@medisin.uio.no IL28B genetic variation and treatment response in patients with hepatitis C virus genotype 3 infection. Hepatology 2011 53 3 746 754 10.1002/hep.24154
66. Darling J. M., Aerssens J., Fanning G., Mchutchison J. G., Goldstein D. B., Thompson A. J., Shianna K. V., Afdhal N. H., Hudson M. L., Howell C. D., Talloen W., Bollekens J., De Wit M., Scholliers A., Fried M. W., mfried@med.unc.edu Quantitation of pretreatment serum interferon- γ -inducible protein-10 improves the predictive value of an IL28B gene polymorphism for hepatitis C treatment response. Hepatology 2011 53 1 14 22 10.1002/hep.24056
67. Landrum M. L., Hullsiek K. H., Ganesan A., Weintrob A. C., Crum-Cianflone N. F., Barthel R. V., Peel S., Agan B. K., Hepatitis B vaccine responses in a large U.S. military cohort of HIV-infected individuals: another benefit of HAART in those with preserved CD4 count. Vaccine 2009 27 34 4731 4738 2-s2.0-67649467275 10.1016/j.vaccine.2009.04.016
68. Wichajarn K., Kosalaraksa P., Wiangnon S., Incidence of hepatocellular carcinoma in children in Khon Kaen before and after national hepatitis B vaccine program. Asian Pacific Journal of Cancer Prevention 2008 9 3 507 510 2-s2.0-67650925040
69. Chongsrisawat V., Yoocharoen P., Theamboonlers A., Tharmaphornpilas P., Warinsathien P., Sinlaparatsamee S., Paupunwatana S., Chaiear K., Khwanjaipanich S., Poovorawan Y., Hepatitis B seroprevalence in Thailand: 12 Years after hepatitis B vaccine integration into the national expanded programme on immunization. Tropical Medicine and International Health 2006 11 10 1496 1502 2-s2.0-33749034174 10.1111/j.1365-3156.2006.01709.x (Pubitemid 44450554)
70. Poovorawan Y., Chongsrisawat V., Theamboonlers A., Bock H. L., Leyssen M., Jacquet J. M., Persistence of antibodies and immune memory to hepatitis B vaccine 20 years after infant vaccination in Thailand. Vaccine 2010 28 3 730 736 2-s2.0-71149083714 10.1016/j.vaccine.2009.10.074
71. Poovorawan Y., Yong.P@chula.ac.th Chongsrisawat V., Theamboonlers A., Leroux-Roels G., Kuriyakose S., Leyssen M., Jacquet J.-M., Evidence of protection against clinical and chronic hepatitis B infection 20 years after infant vaccination in a high endemicity region. Journal of Viral Hepatitis 2011 18 5 369 375 10.1111/j.1365-2893.2010.01312.x
72. Poovorawan Y., Chongsrisawat V., Theamboonlers A., Srinivasa K., Hutagalung Y., Bock H. L., Hoet B., Long-term benefit of hepatitis B vaccination among children in Thailand with transient hepatitis B virus infection who were born to hepatitis B surface antigen-positive mothers. Journal of Infectious Diseases 2009 200 1 33 38 2-s2.0-67650682776 10.1086/599331
73. Poordad F., fred.poordad@cshs.org McCone Jr. J., Bacon B. R., Bruno S., Manns M. P., Sulkowski M. S., Jacobson I. M., Reddy K. R., Goodman Z. D., Boparai N., DiNubile M. J., Sniukiene V., Brass C. A., Albrecht J. K., Bronowicki J.-P., Boceprevir for untreated chronic HCV genotype 1 infection. New England Journal of Medicine 2011 364 13 1195 1206 10.1056/NEJMoa1010494
74. Bacon B. R., baconbr@slu.edu Gordon S. C., Lawitz E., Marcellin P., Vierling J. M., Zeuzem S., Poordad F., Goodman Z. D., Sings H. L., Boparai N., Burroughs M., Brass C. A., Albrecht J. K., Esteban R., Boceprevir for previously treated chronic HCV genotype 1 infection. New England Journal of Medicine 2011 364 13 1207 1217 10.1056/NEJMoa1009482
75. McHutchison J. G., Manns M. P., Muir A. J., Terrault N. A., Jacobson I. M., Afdhal N. H., Heathcote E. J., Zeuzem S., Reesink H. W., Garg J., Bsharat M., George S., Kauffman R. S., Adda N., Di Bisceglie A. M., Telaprevir for previously treated chronic HCV infection. New England Journal of Medicine 2010 362 14 1292 1303 2-s2.0-77950817619 10.1056/NEJMoa0908014
76. McHutchison J. G., Everson G. T., Gordon S. C., Jacobson I. M., Sulkowski M., Kauffman R., McNair L., Alam J., Muir A. J., Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection. New England Journal of Medicine 2009 360 18 1827 1838 2-s2.0-65449152185 10.1056/NEJMoa0806104
77. Sherman K. E., shermake@ucmail.uc.edu Flamm S. L., Afdhal N. H., Nelson D. R., Sulkowski M. S., Everson G. T., Fried M. W., Adler M., Reesink H. W., Martin M., Sankoh A. J., Adda N., Kauffman R. S., George S., Wright C. I., Poordad F., Response-guided telaprevir combination treatment for hepatitis C virus infection. New England Journal of Medicine 2011 365 11 1014 1024 10.1056/NEJMoa1014463
78. Deming P., pdeming@salud.unm.edu McNicholl I. R., Coinfection with human immunodeficiency virus and hepatitis C virus: challenges and therapeutic advances-insights from the Society of Infectious Diseases Pharmacists. Pharmacotherapy 2011 31 4 357 368 10.1592/phco.31.4.357
79. Dore G. J., gdore@kirby.unsw.edu.au Matthews G. V., Rockstroh J., Future of hepatitis C therapy: development of direct-acting antivirals. Current Opinion in HIV and AIDS 2011 6 6 508 513 10.1097/COH.0b013e32834b87f8